Introduction The purpose of this study was to compare the clinical and radiological outcomes of AO/OTA type 31A2 fractures treated by the use of trochanteric nails either with a blade or a screw. Patients and Methods This study was designed retrospectively. Between May 2007 and May 2014, a total of 144 patients with trochanteric fractures were admitted to the clinic, and only 65 of them met the inclusion criteria. Thirty-two of them (blade group) were treated with a helical blade and the rest of the 33 patients (screw group) were treated with a screw. The mean ages of the patients were 76.01 and 75.82, respectively (p = 0.905). The mean follow-up time was 27.6 months (blade group: 34.2 ± 19.1 months; screw group: 18.6 ± 7.9 months; p < 0.001). Between these two groups, we evaluated the differences in tip apex distances (TAD), calcar-referenced tip-apex distances (Cal-TAD), implant positions, cut-out rates, and implant failures. Functional outcomes were measured with the help of the Harris Hip Score. Results No significant differences were seen between the blade and screw groups by means of cutting out, implant positions, and varus collapse. Cutting out was seen in a total of six patients (blade group n = 2; screw group = 4; p = 0.672) and varus collapse in nine patients (blade group n = 5, screw group n = 4; p = 0.733). Harris Hip Scores were similar between the two groups (blade group: 72.70 ± 18.43; screw group: 80.83 ± 18.75; p = 0.84).
Introduction: Osteoid osteoma (OO) is a painful benign bone tumor. Typically, it causes pain that is most noticeable during the night, which is improved by nonsteroidal anti-inflammatory drugs. In the treatment of symptomatic lesions, open surgery for nidus removal is the gold standard. However, surgical technical difficulties and morbidities vary by location. Percutaneous radiofrequency ablation (RFA) therapy guided by computed tomography (CT) is now a popular treatment option for OO. This study aims to assess our single-center experience with the technique, complications, and procedure effectiveness. Materials and Methods: The study included fifteen patients who were treated between 2017 and 2021. A retrospective analysis was carried out on archive images and file records. The lesions' location, nidus width, and affected area (cortical, medullary) were all recorded. The procedure and technical success, as well as postoperative complications and the need for repeat ablation, were all documented. Results: A total of 20 patients, 18 men, and 2 women, were included in the study, and 12 of them were pediatric patients. The patients' mean age was 16.9±7.3 years old, and the mean nidus diameter was 7.1±8.7 mm. There were 13 cortical niduses, 2 intramedullary niduses, and 5 corticomedullary niduses. The lesions were in the femur (n=12), tibia (n=6), scapula (n=1), and vertebrae (n=1). Two recurrences (10%) were observed in our patients during the follow-up. Patient with a femoral OO, the pain started again 12 weeks after the procedure and we performed additional RFA. The patient with vertebral OO had fewer symptoms and full recovery was not achieved. Therefore, the vertebral OO was ablated again 4 months later, and clinical success was achieved. One patient had a minor burn at the entry site that went away on its own after a short period of time. Except for the patient who was scheduled for a repeat RFA, no recurrence has been observed so far. The primary and secondary success rates are, respectively, 90% (18/20) and 100% (20/20). Conclusion: RFA has a high success rate in treating OO. The procedure failure and recurrence rates are low. There are possibilities for posttreatment pain relief, early discharge, and a quick return to daily life. For inappropriate lesion localization, the RFA process replaces surgical treatment. The procedure-related complication rate is low. On the other hand, the burn during the procedure can be a serious problem.
Bu çalışmada 2007-2015 tarihleri arasında Ortopedi ve Travmatoloji Kliniğinde cerrahi yolla tedavi edilen Torakolomber vertebra kırığı bulunan 17 olgunun retrospektif değerlendirilmesi yapıldı. Gereç ve Yöntemler: Çalışmaya dahil edilen hastaların en genci 20, en yaşlısı 63 yaşındaydı ve hastaların yaş ortalaması 43.05 ±13,25 olarak belirlendi. Bu çalışmadaki 17 hastanın 9 'u (%52.9) kadın, 8'si (%47.1) ise erkekti. Etyolojik faktör 7 olguda (%41,2) yüksekten düşme ,7 olguda (%41,2) trafik kazası, 2 olguda (%11,8) araç dışı trafik kazası ve 1 olguda (%5,9) darp idi. Olguların beşinde (%29,4) L3, üçünde (%17,6) L1, üçünde (%17,6) T12 ,ikisinde (%11,8) T8 ve bir hastada (%5,9) T10 ,bir hastada (%5,9) L2 ve bir hastada (%5,9) L4 ve bir hastada da (%5,9) L5 kırık idi. Hastaların %82,4 ini patlama tarzı kırıklar oluşturmaktadır. Ek yaralanmalara bakıldığında ise en sık fıbula şaft kırığı yaralanması görülmektedir. Bulgular: Hastaların hepsine posterior spinal segmental enstrumantasyon uygulandı. Tüm olgularda füzyon amacı ile hastanın kendi kemikleri karıştırılarak kullanıldı. Operasyonlarda ortalama 2 ,05 ünite kan kullanılmıştır.1 hastada implant kırılması ve yetmezliği görüldü. Hastaların ameliyat öncesinde , ameliyat sonrasında ve son kontrollerde klinik ve radyolojik sonuçları değerlendirildi. Ölçülen radyolojik parametreler ayakta yan grafilerde ; anterior korpus yükseklik kaybı , sagittal indeks , lokal kifoz açısı ,anterior kompresyon açısı yer almakta idi. Ayrıca 17 hastanın, ameliyat öncesi ve son kontrollerdeki bilgisayarlı tomografide transvers ve ön-arka spinal kanal çapları değerlendirildi. Son kontrollerde hastaların klinik gözlemleri vizüel analog skala (VAS), Roland-Morris skalası ve Oswestry skorlama sistemi kullanıldı ve değerlendirildi. Sonuç: Klinik memnuniyette radyolojik parametrelerdeki düzelmeden ziyade kanal remodelasyonun daha etkın olduğu sonucuna vardık.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.